Improving breast cancer screening in rural Ghana
Official title: Testing Approaches to Promote Breast Cancer Screening in Rural Ghana
Funded at Pennsylvania State University, the · NIH-10832693 · Data updated 2026-11-12
This study is working to help women in rural Ghana get screened for breast cancer more easily by tackling issues like transportation costs and cultural beliefs, and it includes programs that educate both women and their male partners to support better health choices together.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project start | April 21, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $172,345 |
| NIH project number | 5R21CA280183-02 |
| Project ID | NIH-10832693 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women living in rural Ghana, particularly those who may face barriers to accessing breast cancer screening.
✕Less likely to help
Patients who do not reside in rural Ghana or those who are not women may not receive benefits from this research.
What this research studies
This research aims to increase breast cancer screening rates among women in rural Ghana by addressing key barriers such as transportation costs, cultural beliefs, and male decision-making dominance. The project involves two main interventions: the BUNDLING intervention, which combines breast cancer and diabetes education with simultaneous screenings to reduce stigma and logistical challenges, and the MEGH Program, which engages male partners in education and discussion to support women's health decisions. By implementing these strategies, the research seeks to promote early detection of breast cancer, ultimately improving health outcomes for women in the region.
Why it matters
Potential benefit: If successful, this research could significantly increase breast cancer screening rates and improve early detection, leading to better survival outcomes for women in rural Ghana.
How similar studies have gone: Similar approaches to increasing cancer screening rates have shown promise in other regions, suggesting that this research could build on successful strategies.
Where this research is happening
-
Pennsylvania State University, the
University Park, United States Active
Researchers
- Principal investigator: Acharya, Yubraj — Pennsylvania State University, the
- Study coordinator: Acharya, Yubraj
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.